Incyte Corporation vs Sirius XM Holdings Inc — how do they compare? Incyte Corporation trades at $115.7 (market cap $23.11B), while Sirius XM Holdings Inc trades at $30.27 (market cap $10.30B). The key difference: Incyte Corporation is far larger — about 2.2× Sirius XM Holdings Inc's market cap, and Sirius XM Holdings Inc pays a 3.53% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.
| INCY | SIRI | |
|---|---|---|
Market Cap | $23.11B | $10.30B |
Sector | Health | Media |
52-Week High | $118.52 | $31.22 |
52-Week Low | $67.38 | $19.92 |
Enterprise Value | $19.13B | $19.97B |
Dividend Yield | — | 3.53% |
Trailing returns across standard periods
Latest headlines on both assets
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →